Mathematical models Optimizing treatmentThis group develops and applies mathematical models describing clinical pharmacology processes to interpret clinical trial data, perform clinical trial simulations, support drug development decisions, and optimize therapy in the clinic.
- To maximize impact of research by making optimal use of preclinical information and longitudinal clinical data through model-based analyses.
- To facilitate use of advanced pharmacometric methodology in clinical care.
- To support other research groups with population pharmacokinetic-pharmacodynamic data analysis and physiologically based mechanistic modeling.
- To be a center of excellence in pharmacometrics and to train the next generation of researchers.
Related research groups
Research group Pharmacology of antiviral drugs (HIV and HCV)
David Burger's group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new drug-formulations.read more
Research group Pharmacology of anti-tuberculosis drugs
Rob Aarnoutse's research group investigates the pharmacology of existing and new drugs for tuberculosis, using a translational approach that extends from molecular pharmacology to clinical pharmacology studies and to clinical trials, supported by advanced laboratory and modeling techniques.read more